<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - FLUOCINOLONE ACETONIDE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>FLUOCINOLONE ACETONIDE</h1>

        <p><a href="../drugClass/PHP34550.html">CORTICOSTEROIDS (TOPICAL)</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#nationalFunding" data-toggle="tab">National funding/access decisions</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Treatment of visual impairment associated with chronic diabetic macular oedema which is insufficiently responsive to available therapies (specialist use only)</span>,
            </h4>
            <p class="specificity"><span class="route">By intravitreal injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                190 micrograms, to be administered into the affected eye.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Severe inflammatory skin disorders such as eczemas</span>,
                <span class="indication">Psoriasis</span>,
            </h4>
            <p class="specificity"><span class="route">To the skin</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 1&#8211;2 times a day, to be applied thinly, reduce strength as condition responds.</li>
              <li class="dose child"><strong>For children 1&#8211;17 years</strong><br/>
                Apply 1&#8211;2 times a day, to be applied thinly, reduce strength as condition responds.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
            <section class="potency">
              <h3>Potency of preperations</h3>
              <p>Fluocinolone acetonide 0.025% cream, gel, and ointment: potent.</p><p>Fluocinolone acetonide 0.00625% cream and ointment: moderate.</p><p>Fluocinolone acetonide 0.0025% cream: mild.</p>
            </section>
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">intravitreal</ph> use in adults</h3>
              <p>Manufacturer advises avoid unless potential benefit outweighs risk&#8212;no information available.</p>
            </section>
      </section>



      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> blurred vision in adults, cataract in adults, conjunctival haemorrhage in adults, glaucoma in adults, ocular discomfort in adults, raised intra-ocular pressure in adults, reduced visual acuity in adults, vitreous floaters in adults, vitreous haemorrhage in adults,
              </p>
              <p>
                <strong>uncommon:</strong> conjunctival ulcer in adults, endophthalmitis in adults, eye discharge in adults, eye pruritus in adults, headache in adults, iris adhesions in adults, iris neovascularisation in adults, maculopathy in adults, ocular hyperaemia in adults, optic atrophy in adults, optic nerve disorder in adults, posterior capsule opacification in adults, retinal exudates in adults, retinal vascular occlusion in adults, sclera thinning in adults, vitreous degeneration in adults, vitreous detachment in adults,
              </p>
        
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravitreal</ph> use in adults</h3>
              <p>Concurrent administration to both eyes not recommended. For further information on administration and repeat dosing, consult product literature.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use</h3>
              <p>Patient counselling is advised for fluocinolone acetonide cream, gel and ointment (application).</p>
            </section>
      </section>

      <section class="tab-pane" id="nationalFunding">
        <h2>National funding/access decisions</h2>

            <section class="niceTechnologyAppraisals">
              <h3 class="fundingIdentifier">NICE TA301</h3>
              <p outputclass="specificity">With <ph outputclass="route">intravitreal</ph> use in adults</p> <p outputclass="title">Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (November 2013)</p> <p>Fluocinolone acetonide intravitreal implant is recommended as an option for treating chronic diabetic macular oedema that is insufficiently responsive to available therapies only if:</p> <ul> <li>the implant is to be used in an eye with an intra-ocular (pseudophakic lens) <b>and</b> </li> <li>the manufacturer provides fluocinolone acetonide intravitreal implant with the discount agreed in the patient access scheme.</li> </ul><xref format="html" href="http://www.nice.org.uk/TA301">www.nice.org.uk/TA301</xref>
                <a href="http://www.nice.org.uk/TA301" target="_blank">www.nice.org.uk/TA301</a>
            </section>
      </section>


      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>With intravitreal use:</strong>
            raised baseline intra-ocular pressure in adults
          </li>
        </ul>
      </section>


      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        
            <section class="patientParameters">
              <h3 class="specificity">With <ph outputclass="route">intravitreal</ph> use in adults</h3>
              <p>Monitor for raised intra-ocular pressure (particularly if raised at baseline), retinal detachment, endophthalmitis, vitreous haemorrhage or detachment within 2&#8211;7 days following the procedure.</p><p>Monitor intra-ocular pressure at least every 3 months thereafter (for approximately 36 months).</p>
            </section>
      </section>

      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use in children</h3>
              <p>Not licensed for use in children under 1 year.</p>
            </section>
      </section>

      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <p>Gel is useful for application to the scalp and other hairy areas.</p>
            </section>
      </section>









      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of FLUOCINOLONE ACETONIDE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        

            <div id="PHP76229"><a href="../medicinalForm/PHP76229.html" data-target="#PHP76229" data-action="load">Cream</a></div>
            <div id="PHP76242"><a href="../medicinalForm/PHP76242.html" data-target="#PHP76242" data-action="load">Ointment</a></div>
            <div id="PHP76222"><a href="../medicinalForm/PHP76222.html" data-target="#PHP76222" data-action="load">Gel</a></div>
            <div id="PHP76249"><a href="../medicinalForm/PHP76249.html" data-target="#PHP76249" data-action="load">Implant</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
